This new report provides granular analysis of the diagnostic testing market, including 2023 supplier shares, strategies, as well as 2023-2028 volume and sales forecasts for 500 tests within the following market segments:
- Blood Banking
- Cancer
- Chemistry
- Coagulation
- Drugs of Abuse
- Endocrine
- Hematology and Flow Cytometry
- Immunoprotein
- Infectious Diseases
- Molecular Diagnostics
- TDM
The report profiles over 70 companies, including:
- Abbott
- Agilent Technologies
- Applied Gene Technologies
- Arca Biopharma
- Beckman Coulter/Cepheid/Danaher
- Becton Dickinson
- Bio/Data
- Biokit
- bioMerieux
- Bio-Rad
- CellaVision
- Chrono-Log
- Corgenix
- Decode Genetics
- Diagnostica Stago
- Diamedix
- DiaSorin
- Diazyme
- Eiken Chemical
- EKF Diagnostics
- Elitech Group
- Enzo Biochem
- Epigenomics
- Erba Mannheim
- Exact Sciences
- Fujifilm Wako
- Fujirebio
- Grifols
- Guided Therapeutics
- Helena Laboratories
- Hologic
- Horiba
- HYPHEN BioMed
- Illumina
- Immucor
- Instrumentation Laboratory/Werfen
- Kyowa Medex
- Leica Biosystems
- Li-Cor Biosciences
- Lonza
- Mindray
- Myriad Genetics
- Nexus Dx
- Nihon Kohden
- OncoLab
- PerkinElmer
- Polymedco
- Proteome Sciences
- Qiagen
- Quest Diagnostics
- QuidelOrtho
- Roche
- Scienion
- Sekisui Diagnostics
- SeraCare
- Shimadzu
- Siemens Healthineers
- Sienco
- Sierra Molecular
- Sysmex
- Takara Bio
- Tecan
- Thermo Fisher
- Tosoh
